用于根除幽门螺杆菌感染和与黏液相互作用的凝集素偶联微球。
Lectin-conjugated microspheres for eradication of Helicobacter pylori infection and interaction with mucus.
机构信息
Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield HD1 3DH, UK.
Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield HD1 3DH, UK.
出版信息
Int J Pharm. 2014 Aug 15;470(1-2):28-40. doi: 10.1016/j.ijpharm.2014.04.070. Epub 2014 May 2.
Using second generation mucoadhesives may enhance targeting antibiotics for eradication of Helicobacter pylori from the stomach for the treatment of peptic ulcer. The aim of this research was to prepare and characterise ethylcellulose/chitosan microspheres containing clarithromycin with their surfaces functionalised with concanavalin A to produce a floating-mucoadhesive formulation. The microspheres were prepared using an emulsification-solvent evaporation method. Particle size, surface morphology, in vitro buoyancy profile, zeta potential, drug entrapment efficiency, in vitro drug release and release kinetics of the particles were determined. Lectin was conjugated to the microsphere surface using two-stage carbodiimide activation and confirmed using FTIR, fluorescence studies and zeta potential measurements. Conjugation ranged from 11 to 15 μg Con A/mg microspheres which represents over 56% efficiency although there was some drug loss during the conjugation process. Conjugation did not have a significant effect on the buoyancy and release of drug from the microspheres using a mucus diffusion model with 53% and 40% of drug released from unconjugated and conjugated microspheres within 12h. Conjugation improved mucoadhesion and interaction with porcine gastric mucin compared to unconjugated microspheres. The buoyancy and improved mucoadhesion of the microspheres provides potential for delivery of clarithromycin and other drugs to the stomach.
使用第二代黏膜黏附剂可以增强抗生素的靶向性,以根除胃中的幽门螺杆菌,从而治疗消化性溃疡。本研究旨在制备并表征载克拉霉素的乙基纤维素/壳聚糖微球,其表面用刀豆球蛋白 A 进行功能化,以制备一种漂浮型黏膜黏附制剂。采用乳化-溶剂蒸发法制备微球。测定了微球的粒径、表面形态、体外漂浮性能、Zeta 电位、载药量、体外药物释放率和释放动力学。通过两步碳化二亚胺活化法将凝集素偶联到微球表面,并用傅里叶变换红外光谱(FTIR)、荧光研究和 Zeta 电位测量进行确认。偶联物的范围为 11-15μg Con A/mg 微球,代表超过 56%的效率,尽管在偶联过程中有一些药物损失。在使用黏液扩散模型时,偶联对药物从微球中的释放没有显著影响,未偶联和偶联的微球在 12 小时内分别释放了 53%和 40%的药物。与未偶联的微球相比,偶联物提高了微球的黏膜黏附性和与猪胃黏蛋白的相互作用。微球的漂浮性和改善的黏膜黏附性为克拉霉素和其他药物向胃部的传递提供了潜力。